IndraLab

Statements


1 | 7

reach
"These results suggest that leupeptin treatment caused significant inhibition of the intracellular maturation of cathepsin L."

reach
"HIV-luc(ACE2) and HIV(SARS-CoV S/ASLV-A env) particles were mixed, pre-incubated at 37 o C and then treated with PBS, trypsin (10 µg/ml), or cathepsin L or B (2 µg/ml) for 10 minutes at 25 o C. Proteases were inactivated by leupeptin (20 µg/ml), incubated at 37 o C for 30 minutes to allow membrane fusion and plated on HeLa/Tva cells pretreated with leupeptin (20 µg/ml)."

reach
"Injection of leupeptin or E-64 into rats actually inhibits the activities of cathepsin B and cathepsin L in the lysosomal fraction of liver and results in inhibition of turnover rate of liver aldolase[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Leupeptin and E-64 dose dependently inhibited both cathepsin B and cathepsin L activities, and pepstatin A strongly inhibited cathepsin D activity in rat kidney lysosomes."

No evidence text available

reach
"Injection of leupeptin into rats [1] actually inhibits the activities of cathepsin B and cathepsin L in the lysosomal fraction of the liver cells."

reach
"Previously [1] we found that administration of leupeptin or E-64 to rats inhibited the lysosomal cathepsin B and cathepsin L activity in their liver."

reach
"SARS-CoV infection was blocked by specific inhibitors of the pH-sensitive endosomal protease cathepsin L. S-mediated entry into Vero E6 and 293T/hACE2 cells was blocked by leupeptin, Z-lll-FMK (an inhibitor of both CTSB and CTSL), and E64c (an inhibitor of cysteine proteases) [21]."